Airstrikes Target Iran’s Pharma Facilities, Disrupt Global Medicine Supply

The conflict between the United States, Israel, and Iran has intensified, leading to airstrikes on Iran’s pharmaceutical and medical infrastructure. As of March 11, 2026, the World Health Organization (WHO) confirmed 18 attacks on healthcare facilities, resulting in eight deaths among health workers. The Iranian government reported a higher toll, citing 307 damaged health, medical, and emergency care facilities as of April 2026, including the destruction of four ambulances and one ambulance helicopter. Targets included the Tofigh Daru pharmaceutical facility, which produces cancer treatments, and the Pasteur Institute, a psychiatric hospital, among other hospitals outside Tehran. International law experts, including professors from Harvard, Yale, and Stanford, condemned the strikes as a ‘clear violation of the United Nations Charter.’

The discrepancy between the WHO’s verified attacks and Iranian figures highlights challenges in assessing war-related damage. The WHO’s count of 18 attacks is based on verified reports and international monitoring, while Iranian officials and the Red Crescent documented 307 damaged facilities. The Iranian Red Crescent reported 52 healthcare facilities, 29 treatment centers, 19 emergency care centers, and 16 ambulances damaged, with four ambulances and one ambulance helicopter destroyed. These figures, though not independently verified, reflect the scale of the crisis as perceived by Iranian authorities.

Disrupted Supply Chains and Global Medicine Shortages

“clear violation of the United Nations Charter”

The bombing of Iran’s pharmaceutical facilities has disrupted global supply chains for critical medicines. The Persian Gulf, a major pharmaceutical transit hub, has seen its shipping lanes severely disrupted, with sea cargo down 90% and air cargo capacity in the region down 79% compared to pre-war levels. This has impacted cold-chain medicines—vaccines, insulin, biologics, and cancer therapies—which require strict temperature control and rapid transit. Airlines cannot quickly expand capacity to replace lost shipments, leading to delays and potential spoilage. Cargo carriers require 1.5 weeks to recover for every week of suspended air shipments, exacerbating the crisis. Additionally, helium supplies, essential for MRI machines, are at risk due to an attack on a major helium production site in Qatar, which produces a third of the world’s helium. These disruptions threaten both medical treatments and diagnostic capabilities worldwide.

Impact on Patients and Medical Access

The disruption of pharmaceutical supply chains has also affected the availability of medicines in neighboring countries. The Gulf region’s pharmaceutical industry, worth $23.7 billion, relies heavily on transit through the Persian Gulf for 80% of its trade. The collapse of these routes has forced rerouting through alternative paths, increasing costs and delays. A report by the Council on Foreign Relations notes that rerouted flights and higher air-cargo rates could lead to a 10–15% increase in drug prices within six months. This is particularly concerning for low-income countries that depend on imported medicines, as price hikes could make essential treatments unaffordable. The situation is further complicated by the fact that many critical drugs, such as insulin and chemotherapy agents, are produced in India and China, which are also affected by regional instability and trade restrictions.

The attacks on Iran’s healthcare infrastructure have placed thousands of patients in dire straits, particularly those requiring chronic treatments and cancer therapies. The Tofigh Daru facility, which produces essential cancer drugs, was destroyed by a direct missile strike, disrupting the domestic supply chain and making imports difficult. Dr. Hassan Nayeb-Hashem, a veteran doctor, warned that cancer patients now face severe challenges, with medication costs equivalent to one or two monthly salaries and limited insurance coverage. The Iranian Red Crescent reported that over 100,000 people have been displaced due to the conflict, further straining healthcare resources. Many experienced doctors have left Iran due to security risks, leading to severe understaffing in non-capital cities. A cancer patient in Tehran reportedly could not obtain basic medications, highlighting the dire humanitarian impact of the strikes.

Mental Health Crisis and Systemic Strain

The crisis has also affected mental health services, as the Pasteur Institute, a psychiatric hospital, was damaged in the attacks. This has left many patients without access to critical mental health care, exacerbating existing challenges in Iran’s mental health system. The Iranian government has acknowledged the strain on healthcare workers, with over 1,300 deaths and 9,000 injuries reported in the country. The combination of physical injuries, displacement, and the collapse of medical infrastructure has created a perfect storm of humanitarian needs. For example, the destruction of medical facilities has led to shortages of basic supplies such as antiseptics and surgical tools, forcing hospitals to ration resources. In some cases, patients have had to wait hours for basic treatments, with delays in emergency care increasing the risk of complications or death.

International Condemnation and Legal Implications

The international community has condemned the attacks on Iran’s healthcare facilities as potential war crimes under the Geneva Conventions. The WHO emphasized that healthcare facilities, workers, and patients must be protected under international humanitarian law, stating that attacks on medical infrastructure constitute a violation of these principles. Iranian Deputy Health Minister Mehdi Pirsalehi confirmed that the Tofigh Daru facility was targeted by a ‘direct missile strike,’ destroying production lines and research departments. Israel admitted to the attack but alleged that the facility used its civilian status to ‘systematically supply chemicals’ for Iran’s chemical weapons research. Over 100 US-based international law experts, including professors from Harvard, Yale, and Stanford, condemned the airstrikes as a ‘clear violation of the United Nations Charter,’ citing reports of 236 bombed health centers.

Systemic Vulnerabilities and Recovery Efforts

“the Tofigh Daru facility was targeted by a 'direct missile strike,' destroying production lines and research departments”

The legal implications of the attacks extend beyond Iran. The WHO’s Tedros Adhanom Ghebreyesus warned that post-war recovery efforts would prioritize military facilities over healthcare, exacerbating long-term crises. This raises concerns about the long-term viability of Iran’s healthcare system, as the focus on rebuilding military infrastructure could delay the restoration of medical services. Additionally, the attacks have drawn attention to the broader issue of targeting civilian infrastructure in modern warfare. The International Committee of the Red Cross (ICRC) has called for stricter adherence to the Geneva Conventions, emphasizing that medical facilities must be protected unless they are directly participating in hostilities. The ICRC also highlighted the need for greater transparency in assessing the damage to healthcare systems, as this is critical for ensuring accountability and preventing future attacks.

Global Health Implications and Future Outlook

The long-term consequences of the airstrikes on Iran’s healthcare system are profound, with potential shortages of critical medicines and a weakened medical research sector. The Healthbeat article notes that while short-term drug shortages are low due to inventory buffers, prolonged disruptions could trigger shortages within four to six weeks. Rising costs from rerouted flights, higher air-cargo rates, and insurance premiums may further strain healthcare budgets. The WHO and other international bodies are urging governments to temporarily loosen import regulations to facilitate alternate supply routes. In the long term, a G20 coordination system to track medicine shortages and improve response is being proposed. Meanwhile, Iran’s government has called for global action, with President Masoud Pezeshkian describing the attacks as ‘crimes against humanity.’ The recovery of Iran’s healthcare system will depend on both domestic resilience and international support to rebuild infrastructure and restore medical services.

Addressing Systemic Vulnerabilities

The recovery process will also require addressing the broader systemic issues that have contributed to the vulnerability of Iran’s healthcare system. For example, the lack of investment in medical infrastructure and the reliance on imported medicines have left the system ill-prepared for large-scale disruptions. Additionally, the exodus of experienced doctors due to security risks has created a brain drain that will take years to reverse. To mitigate these challenges, Iran may need to prioritize rebuilding its domestic pharmaceutical industry and investing in local production of critical medicines. International aid organizations and pharmaceutical companies could play a key role in this effort, providing both financial support and technical expertise to restore medical services.

The global community must also recognize the broader implications of the attacks on Iran’s healthcare system. The destruction of medical infrastructure in one country has far-reaching consequences for global health, as the interconnectedness of supply chains means that disruptions in one region can affect medicines and treatments worldwide. This underscores the need for a coordinated international response to protect healthcare systems during times of conflict. As the WHO and other organizations continue to monitor the situation, the focus must remain on ensuring that medical facilities are protected and that patients have access to the care they need, regardless of political tensions. The long-term recovery of Iran’s healthcare system will not only determine the well-being of its citizens but also set a precedent for how global health infrastructure is safeguarded in the face of ongoing conflicts.